MyD88: At the heart of inflammatory signaling and cardiovascular disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MyD88: At the heart of inflammatory signaling and cardiovascular disease
Authors
Keywords
Cardiovascular disease, Inflammation, MyD88, Alarmin signaling
Journal
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Volume 161, Issue -, Pages 75-85
Publisher
Elsevier BV
Online
2021-08-08
DOI
10.1016/j.yjmcc.2021.08.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro
- (2020) Zhimiao Zou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipopolysaccharides improves mesenchymal stem cell-mediated cardioprotection via MyD88 and stat3 signaling in a mouse model of cardiac ischemia/reperfusion injury
- (2019) Xiaona Chu et al. STEM CELLS AND DEVELOPMENT
- Angiotensin II-induced Hypertension and Cardiac Hypertrophy are Differentially Mediated by TLR3- and TLR4-Dependent Pathways
- (2019) Madhu V Singh et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Heart inflammation: immune cells roles and roads to the heart.
- (2019) Francisco J. Carrillo-Salinas et al. AMERICAN JOURNAL OF PATHOLOGY
- Cytokine Circuits in Cardiovascular Disease
- (2019) Jesse W. Williams et al. IMMUNITY
- A novel MyD88 inhibitor LM9 prevents atherosclerosis by regulating inflammatory responses and oxidative stress in macrophages
- (2019) Taiwei Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- IL‐1 Receptor Antagonist, Anakinra, Prevents Myocardial Dysfunction in a Mouse Model of Kawasaki Disease Vasculitis and Myocarditis
- (2019) Mark Gorelik et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
- (2019) Iris L A Bodewes et al. RHEUMATOLOGY
- Loss of MD1 increases vulnerability to ventricular arrhythmia in diet-induced obesity mice via enhanced activation of the TLR4/MyD88/CaMKII signaling pathway
- (2019) Wei Shuai et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Role of Inflammatory Cell Subtypes in Heart Failure
- (2019) Derek Strassheim et al. Journal of Immunology Research
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- Simvastatin Downregulates Osteogenic Response in Cultured Human Aortic Valve Interstitial Cells
- (2019) Michael J. Jarrett et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- TLR4 (Toll-Like Receptor 4)-Dependent Signaling Drives Extracellular Catabolism of LDL (Low-Density Lipoprotein) Aggregates
- (2019) Rajesh K. Singh et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury
- (2018) Qiang Su et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Interleukin-1 blockade in cardiovascular diseases: a clinical update
- (2018) Leo F Buckley et al. EUROPEAN HEART JOURNAL
- Differential role of MyD88 and TRIF signaling in myeloid cells in the pathogenesis of autoimmune diabetes
- (2018) Ariadne Androulidaki et al. PLoS One
- Understanding early TLR signaling through the Myddosome
- (2018) Katherine R. Balka et al. JOURNAL OF LEUKOCYTE BIOLOGY
- MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling
- (2018) Dongdong Zheng et al. Clinical Research in Cardiology
- Development of 2-amino-4-phenylthiazole analogues to disrupt myeloid differentiation factor 88 and prevent inflammatory responses in acute lung injury
- (2018) Lingfeng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent clinical trends in Toll-like receptor targeting therapeutics
- (2018) Muhammad Ayaz Anwar et al. MEDICINAL RESEARCH REVIEWS
- HMGB1 and repair: focus on the heart
- (2018) Laura Pellegrini et al. PHARMACOLOGY & THERAPEUTICS
- Alarmins and immunity
- (2017) De Yang et al. IMMUNOLOGICAL REVIEWS
- TLR3 contributes to persistent autophagy and heart failure in mice after myocardial infarction
- (2017) Ting Gao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure
- (2017) Tania Nevers et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Myd88 is required for disease development in a primary Sjögren’s syndrome mouse model
- (2017) Jeremy Kiripolsky et al. JOURNAL OF LEUKOCYTE BIOLOGY
- S100A8/MYD88/NF-қB: a novel pathway involved in cardiomyocyte hypertrophy driven by thyroid hormone
- (2017) Ana Paula Cremasco Takano et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- IL-37 Suppresses MyD88-mediated Inflammatory Responses in Human Aortic Valve Interstitial Cells
- (2017) Qiong Zhan et al. MOLECULAR MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation
- (2017) Chao Li et al. TRANSPLANTATION
- Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats
- (2016) Cameron G. McCarthy et al. AMERICAN JOURNAL OF HYPERTENSION
- Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes
- (2016) Fanqi Kong et al. BIOMEDICINE & PHARMACOTHERAPY
- Viral myocarditis
- (2016) Noel R. Rose CURRENT OPINION IN RHEUMATOLOGY
- Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway
- (2016) Wei Gao et al. ENDOCRINOLOGY
- Imiquimod in dermatology: an overview
- (2016) Edith Hanna et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Inflammatory processes in cardiovascular disease: a route to targeted therapies
- (2016) Neil Ruparelia et al. Nature Reviews Cardiology
- Modulation of endothelial function by Toll like receptors
- (2016) Beatriz Salvador et al. PHARMACOLOGICAL RESEARCH
- Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice
- (2016) Gustavo Monnerat et al. Nature Communications
- Toll-Like Receptor 4 Is Essential in the Development of Abdominal Aortic Aneurysm
- (2016) Chao-Han Lai et al. PLoS One
- IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse ModelSignificance
- (2015) Youngho Lee et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TRIF adaptor signaling is important in abdominal aortic aneurysm formation
- (2015) Emina Vorkapic et al. ATHEROSCLEROSIS
- Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension
- (2015) R Hernanz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart FailureCLINICAL PERSPECTIVE
- (2015) Tania Nevers et al. Circulation-Heart Failure
- Dual Activation of TRIF and MyD88 Adaptor Proteins by Angiotensin II Evokes Opposing Effects on Pressure, Cardiac Hypertrophy, and Inflammatory Gene ExpressionNovelty and Significance
- (2015) Madhu V. Singh et al. HYPERTENSION
- Activation of TLR3 Induces Osteogenic Responses in Human Aortic Valve Interstitial Cells through the NF-κB and ERK1/2 Pathways
- (2015) Qiong Zhan et al. International Journal of Biological Sciences
- Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction
- (2015) Li Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats
- (2015) G.F. Bomfim et al. LIFE SCIENCES
- Discovery of small molecule inhibitors of MyD88-dependent signaling pathways using a computational screen
- (2015) Mark A. Olson et al. Scientific Reports
- Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer
- (2015) Lin Xie et al. JNCI-Journal of the National Cancer Institute
- Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
- (2014) Vasundhara Kain et al. BASIC RESEARCH IN CARDIOLOGY
- Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
- (2014) Xiao Yuan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases
- (2014) Minjia Yu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Toll-like receptor 4 activation promotes cardiac arrhythmias by decreasing the transient outward potassium current (Ito) through an IRF3-dependent and MyD88-independent pathway
- (2014) Gustavo Monnerat-Cahli et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation
- (2013) Lung-Chih Li et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis
- (2013) Anna M. Lundberg et al. CARDIOVASCULAR RESEARCH
- Toll-like receptor regulation of effector T lymphocyte function
- (2013) Joseph M. Reynolds et al. TRENDS IN IMMUNOLOGY
- Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats
- (2012) Gisele F. Bomfim et al. CLINICAL SCIENCE
- The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice
- (2012) M Rachel Richards et al. Innate Immunity
- Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs
- (2012) Manikandan Subramanian et al. JOURNAL OF CLINICAL INVESTIGATION
- MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction
- (2012) Madhu V. Singh et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
- (2012) M. R. Hutchinson et al. JOURNAL OF NEUROSCIENCE
- MyD88 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Independent of Signaling Through Toll-Like Receptors 2 and 4
- (2011) A. Phillip Owens et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Aging Enhances the Basal Production of IL-6 and CCL2 in Vascular Smooth Muscle Cells
- (2011) Yang Song et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling
- (2011) Yun Zhu et al. BASIC RESEARCH IN CARDIOLOGY
- Toll-like Receptor 4 Mediates Oxidized LDL-Induced Macrophage Differentiation to Foam Cells
- (2011) Kenneth W. Howell et al. JOURNAL OF SURGICAL RESEARCH
- Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm
- (2011) Joshua M. Spin et al. PHYSIOLOGICAL GENOMICS
- Unexpected protective role for Toll-like receptor 3 in the arterial wall
- (2011) J. E. Cole et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injury
- (2010) Yan Feng et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo
- (2010) Alexander Riad et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis
- (2010) Philippe P. Pagni et al. AUTOIMMUNITY
- Overview of the immune response
- (2010) David D. Chaplin JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacologic Inhibition of Myeloid Differentiation Factor 88 (MyD88) Prevents Left Ventricular Dilation and Hypertrophy After Experimental Acute Myocardial Infarction in the Mouse
- (2010) Benjamin W Van Tassell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Canakinumab
- (2010) Eugen Dhimolea mAbs
- The cardioprotective effect of fluvastatin on ischemic injury via down-regulation of toll-like receptor 4
- (2010) Jun Yang et al. MOLECULAR BIOLOGY REPORTS
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity
- (2010) M.R. Hutchinson et al. NEUROSCIENCE
- Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes
- (2009) Giuseppe M. Campo et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Evidence that opioids may have toll-like receptor 4 and MD-2 effects
- (2009) Mark R. Hutchinson et al. BRAIN BEHAVIOR AND IMMUNITY
- The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury
- (2009) Z. Cao et al. CARDIOVASCULAR RESEARCH
- Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy
- (2009) Przemyslaw Blyszczuk et al. CIRCULATION RESEARCH
- MyD88-dependent nuclear factor-κB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes
- (2009) Ting Li et al. JOURNAL OF HYPERTENSION
- Pro-Osteogenic Phenotype of Human Aortic Valve Interstitial Cells Is Associated With Higher Levels of Toll-Like Receptors 2 and 4 and Enhanced Expression of Bone Morphogenetic Protein 2
- (2009) Xiaoping Yang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Valsartan preconditioning protects against myocardial ischemia–reperfusion injury through TLR4/NF-κB signaling pathway
- (2009) Jian Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection
- (2009) Martin J. Richer et al. PLoS One
- Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice
- (2008) Yan Feng et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
- (2008) Mohan R. Dasu et al. ATHEROSCLEROSIS
- Pyogenic Bacterial Infections in Humans with MyD88 Deficiency
- (2008) H. von Bernuth et al. SCIENCE
- Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure
- (2007) Gábor Földes et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now